FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

CGMP Deviations in DuPont Avicel Manufacturing

FDA warns DuPont Nutrition USA about CGMP deviations in its manufacturing of the widely-used drug excipient Avicel.

Medical Devices

FDA Discusses 2 New Trilogy Ventilator Issues

FDA describes two new issues that have occurred in some reworked Philips Respironics Trilogy 100 and 200 ventilators.

latest-news-card-1
FDA General

FDA Needs More Global Help Against Crime: Hermsen

Retired FDA top cop Catherine Hermsen says there is a need to expand collaboration with regulators in other countries to combat international criminal...

latest-news-card-1
Human Drugs

Reactions to Aduhelm Report Blast FDA Closeness to Industry

Reactions to a Congressional report on FDAs 2021 controversial review and approval of Biogens Alzheimers drug Aduhelm sharply criticize the approval a...

latest-news-card-1
Human Drugs

M11 Clinical Electronic Structured Protocol

FDA publishes an International Council for Harmonization guideline on a clinical electronic structured protocol.

latest-news-card-1
FDA General

FDA Gets $226 Million Spending Boost in Budget Bill

President Biden signs into law FDAs fiscal year 2023 spending bill as part of the end-year omnibus legislation (HR 2617, Consolidated Appropriations A...

latest-news-card-1
Human Drugs

FDA Grants Ardelyx Xphozah Appeal

FDA grants Ardelyx appeal of a complete response letter for its Xphozah to treat adult patients with chronic kidney disease on dialysis with hyperphos...

latest-news-card-1
Federal Register

Latest Federal Register Notices

FDA Webview posts the Federal Register notices that published during our annual holiday break.

latest-news-card-1
Medical Devices

Advanced Bionics Paying $12 Million Over False Claims

Advanced Bionics agrees to pay more than $12 million to the federal government and participating Medicaid states to resolve a whistleblowers suit alle...

latest-news-card-1
Human Drugs

Cytalux Approved for Lung Cancer Lesion Detection

FDA approves an On Target Laboratories supplemental NDA for Cytalux (pafolacianine) to help surgeons in identifying lung cancer lesions.